Cancer discovery | 2019
De Novo Cytokine Mimics Have Improved Therapeutic Properties.
Abstract
A de novo IL2/IL15 mimic has improved antitumor activity and reduced toxicity compared with native IL2.
A de novo IL2/IL15 mimic has improved antitumor activity and reduced toxicity compared with native IL2.